TCWP’s Amneal Pharmaceuticals AMRX Stock Holding History

TCWP’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-693	Closed	-$2K	–	332
2022 Q1	$2K	Buy	+693	New	+$3.07K	﹤0.01%	1276

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TCWP's AMRX Position: Q2 2022 in Review

TCWP sold out of Amneal Pharmaceuticals (AMRX) in Q2 2022, closing a stake of 693 shares — an estimated $2K sold.

TCWP first reported a position in AMRX in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 153 funds tracked by Wall St. Rank hold AMRX as of Q2 2022.

TCWP reported no remaining Amneal Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
TCWP sold 693 Amneal Pharmaceuticals shares in Q2 2022, an estimated $2K.
TCWP first reported a position in Amneal Pharmaceuticals in Q1 2022 and held it in 1 quarter.
TCWP's Amneal Pharmaceuticals position peaked at $2K in Q1 2022.
153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.